These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 782964
21. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B. Vaccine; 2008 Jun 02; 26(23):2912-8. PubMed ID: 18448208 [Abstract] [Full Text] [Related]
23. [Safety of an influenza-split-vaccine in children]. Schmitt-Grohé S, Banzhoff A, Klaassen B, Zielen S. Klin Padiatr; 2001 Jun 02; 213(6):338-42. PubMed ID: 11713714 [Abstract] [Full Text] [Related]
24. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL. Pediatr Infect Dis J; 2007 Feb 02; 26(2):107-15. PubMed ID: 17259871 [Abstract] [Full Text] [Related]
27. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. Wright PF, Ross KB, Thompson J, Karzon DT. N Engl J Med; 1977 Apr 14; 296(15):829-34. PubMed ID: 846492 [Abstract] [Full Text] [Related]
28. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. J Infect Dis; 2015 Oct 15; 212(8):1191-9. PubMed ID: 25858957 [Abstract] [Full Text] [Related]
30. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Wesley RD, Tang M, Lager KM. Vaccine; 2004 Sep 03; 22(25-26):3427-34. PubMed ID: 15308368 [Abstract] [Full Text] [Related]
31. Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West). Werner J, Schudrowitz C, Köhler H. Zentralbl Bakteriol Orig A; 1975 Dec 03; 233(4):440-6. PubMed ID: 56831 [Abstract] [Full Text] [Related]
32. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. J Infect Dis; 2011 Dec 15; 204(12):1879-85. PubMed ID: 21998477 [Abstract] [Full Text] [Related]
33. Challenge versus natural infection as an index or protection after influenza immunization. Donikian MA, McKee J, Greene LC. Dev Biol Stand; 2011 Dec 15; 39():149-54. PubMed ID: 342306 [Abstract] [Full Text] [Related]
34. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. Ogra PL, Chow T, Beutner KR, Rubi E, Strussenberg J, DeMello S, Rizzone C. J Infect Dis; 1977 Apr 15; 135(4):499-506. PubMed ID: 856917 [Abstract] [Full Text] [Related]
35. An attenuated influenza virus vaccine: protection against homologous and heterologous strains of virus. Khakoo R, Ganguly R, Waldman R. Dev Biol Stand; 1977 Apr 15; 39():141-8. PubMed ID: 342305 [Abstract] [Full Text] [Related]
38. Purified viral neuraminidase vaccine to control influenza. Arora DJ. Can Med Assoc J; 1979 Dec 22; 121(12):1575-9. PubMed ID: 394829 [Abstract] [Full Text] [Related]